We are a bioanalytical lab that has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.
BioAgilytix is Your Expert Resource for COVID-19 Testing
We’re committed to applying our specialized clinical assay expertise to help customers test for and understand the impacts of SARS-CoV-2 and the associated COVID-19 disease.
With the complete suite of assays you need & fully operational labs, we’re ready to help today. See how.
Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics & Pharmacodynamics (PK/PD)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
In this webinar, BioAgilytix’s Dr. Corinna Fiorotti takes a closer look at:
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
July 7, 2020Bruton’s Tyrosine Kinase (BTK) Target Occupancy Assays and COVID-19
June 25, 2020Behind the Science Perspectives with Dr. Jim McNally, BioAgilytix’s Chief Scientific Officer
June 30, 2020Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer
June 25, 2020BioAgilytix Welcomes Mike Nicholson, Ph.D. to Leadership Team as Vice President, Operations
March 13, 2020Supporting CAR-T Development
December 6, 2019CRISPR-Cas9 Milestones: The First In Vivo Clinical Trial Is Now Underway
Services
Platforms
